![Bradley Sitko](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bradley Sitko
Chief Investment Officer at
XOMA ROYALTY CORPORATION
Profile
Bradley J.
Sitko is currently Non-Executive Director at LAVA Therapeutics NV since 2025, Director at Mural Oncology Plc since 2025, and Chief Investment Officer at XOMA Royalty Corp.
since 2023.
Former roles include Director at RTW Investments ICAV from 2021 to 2023, Managing Director at RTW Investments LP from 2019 to 2023, Vice President-Finance & Corporate Development at DNAnexus, Inc. from 2015 to 2019, Director at MTS Health Partners LP from 2008 to 2015, Principal at Pfizer Inc., and Chief Financial Officer at CORXEL Pharmaceuticals (Shanghai) Co., Ltd. Education includes undergraduate studies at the University of Pennsylvania and an MBA from Columbia Business School.
Bradley Sitko active positions
| Companies | Position | Start |
|---|---|---|
| XOMA ROYALTY CORPORATION | Chief Investment Officer | 2023-01-02 |
| LAVA THERAPEUTICS | Director/Board Member | 2025-11-06 |
Former positions of Bradley Sitko
| Companies | Position | End |
|---|---|---|
RTW Investments /Venture/
 RTW Investments /Venture/ Investment ManagersFinance RTW Investments invests in companies located in the United States. The firm targets companies operating in the fields of med tech and biopharma sectors. It provides financing for early-stage capital requirements. | Private Equity Investor | 2022-12-31 |
RTW Investments ICAV
 RTW Investments ICAV Investment Trusts/Mutual FundsMiscellaneous Functions as an open-end investment fund | Director/Board Member | 2022-12-31 |
DNAnexus, Inc.
 DNAnexus, Inc. Packaged SoftwareTechnology Services Develops cloud enterprise platform for precision health to development, approval and delivery of personalized treatments | Director of Finance/CFO | 2018-12-31 |
MTS Health Partners LP
 MTS Health Partners LP Investment Banks/BrokersFinance Operates as an investment bank that provides strategic and financial advisory services | Director/Board Member | 2015-02-28 |
Jixing Pharmaceutical Technology (Shanghai) Co. Ltd.
 Jixing Pharmaceutical Technology (Shanghai) Co. Ltd. BiotechnologyHealth Technology Develops and commercializes novel therapeutics for cardiometabolic diseases | Director of Finance/CFO | - |
Education of Bradley Sitko
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
65
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
XOMA Royalty Corp.
 XOMA Royalty Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops antibody therapeutics | Health Technology |
DNAnexus, Inc.
DNAnexus, Inc. Packaged SoftwareTechnology Services Develops cloud enterprise platform for precision health to development, approval and delivery of personalized treatments | Technology Services |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MTS Health Partners LP
MTS Health Partners LP Investment Banks/BrokersFinance Operates as an investment bank that provides strategic and financial advisory services | Finance |
Columbia Business School
 Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
LAVA Therapeutics NV
 LAVA Therapeutics NV Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops antibodies for the treatment of cancer | Health Technology |
RTW Investments /Venture/
RTW Investments /Venture/ Investment ManagersFinance RTW Investments invests in companies located in the United States. The firm targets companies operating in the fields of med tech and biopharma sectors. It provides financing for early-stage capital requirements. | Finance |
RTW Investments ICAV
RTW Investments ICAV Investment Trusts/Mutual FundsMiscellaneous Functions as an open-end investment fund | Miscellaneous |
Jixing Pharmaceutical Technology (Shanghai) Co. Ltd.
Jixing Pharmaceutical Technology (Shanghai) Co. Ltd. BiotechnologyHealth Technology Develops and commercializes novel therapeutics for cardiometabolic diseases | Health Technology |
- Stock Market
- Insiders
- Bradley Sitko
